-
University Activities
Vice-Chancellor to conclude his term in 2025 -
New research from a major retail and dining precinct in China shows retailers who adopt new ecommerce strategies are reinvigorating the city-centres main streets.
-
The University of Melbourne has published its third Sexual Misconduct Annual Report highlighting the University’s commitment to transparency in how it responds to and eliminates sexual misconduct within its community.
-
Australia’s newest biotech incubator Jumar Bioincubator has officially opened its doors and revealed the first 16 innovative early-stage ventures to take up residency in its much-awaited Melbourne-based facility.
-
The latest Indigenous business Snapshot shows Indigenous businesses contribute more than $16 billion to the Australian economy, employ 116,795 people and pay $4.2 billion in wages.
-
An expedition to the southernmost waters encircling Antarctica has discovered that wind drives the formation of colossal rogue waves, and that these unpredictable waves occur more frequently than scientists had previously thought – providing critical information to inform future rogue wave prediction models.
-
Professor Jennifer Balint has been appointed the Dean of the Faculty of Arts at the University of Melbourne.
-
Australia’s first clinical trial facility specifically commissioned to deliver human challenge trials, Doherty Clinical Trials Ltd, was launched today in East Melbourne by The Honourable Ben Carroll MP Minister for Medical Research and Professor Sharon Lewin AO, Director of the Peter Doherty Institute for Infection and Immunity (Doherty Institute).
-
A Federal MP from Tasmania, a recently-elected senator and two premiers who were once opponents have been named as winners of the 2023 McKinnon Prize, Australia’s independent, non-partisan award for outstanding political leadership.
-
International businessman and philanthropist Mr Geoffrey Cumming has been honoured as a Fellow of the University of Melbourne.
-
Genomics-focused biomedical research breakthroughs in cancer, inherited eye disease and common gynaecological disorders are set to be accelerated by a $6.5 million funding boost.